<DOC>
	<DOCNO>NCT00403858</DOCNO>
	<brief_summary>This single centre study comprise two stage ( Parts I II ) . Part I 9-day open label evaluation Movicol administer patient hospital . This study evaluate safety efficacy Movicol treat faecal impaction . Movicol administer 3 - 7 day achieve disimpaction .</brief_summary>
	<brief_title>Movicol Childhood Constipation ( ProMotion Study )</brief_title>
	<detailed_description>Patients receive Movicol treatment disimpaction achieve accord follow regime : Day 1 : Ages 2 – 4 receive 1 ( one ) sachet whilst 5 – 11 year old receive 2 ( two ) . Day 2 : Ages 2 – 4 receive 2 ( two ) sachet whilst 5 – 11 year old receive 3 ( three ) . Day 3 : Ages 2 – 4 receive 2 ( two ) sachet whilst 5 – 11 year old receive 4 ( four ) . Day 4 : Ages 2 – 4 receive 3 *three ) sachets whilst 5 – 11 year old receive 5 ( five ) . Day 5 : Ages 2 – 4 receive 3 ( three ) sachet whilst 5 – 11 year old receive 6 ( six ) . Day 6 : Ages 2 – 4 receive 4 ( four ) sachet whilst 5 – 11 year old receive 6 ( six ) . Day 7 : Ages 2 – 4 receive 4 ( four ) sachet whilst 5 – 11 year old receive 6 ( six ) . If day 8 patient still impact withdrawn study treat accord individual need . Disimpaction assess clinically ( loss faecal mass passage watery stool ) . Two day follow disimpaction patient randomise ( accord randomisation list ) receive Movicol Lactulose Dry . During bowel retrain appropriate maintenance dose Movicol Lactulose Dry determine . Patients discharge pass regular , painless , bowel action .</detailed_description>
	<mesh_term>Fecal Impaction</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>patient , opinion investigator , constipated/fecally impact require hospital stay treat and/or relieve impaction child age 2 11 year old inclusive patient either sex Patients intestinal perforation obstruction severe inflammatory condition intestinal tract uncontrolled renal/hepatic/cardiac disease uncontrolled endocrine disorder ( ) neuromuscular condition affect bowel function hypersensitivity lactulose PEG constituent Movicol patient take investigational drug three month patient patient whose parent would opinion investigator unable comply requirement study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>